Citadel Advisors
MNPR icon

Citadel Advisors’s Monopar Therapeutics MNPR Stock Holding History

Citadel Advisors’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$223K Buy
+6,232
New +$223K ﹤0.01% 4909
2021
Q2 		– Sell
-2,496
Closed -$77K – 6810
2021
Q1 		$77K Buy
+2,496
New +$77K ﹤0.01% 5960